[8] [9] As a precautionary measure, consistent with SmPC guidance for the drug class, retatrutide would be expected to be contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Patients who are pregnant, breastfeeding, or planning pregnancy should not use retatrutide, consistent with guidance applicable to other agents in this class
Combining methods often leads to faster and more sustainable results
As these medications become more widely used for weight management, interest is growing not only in their clinical impact but also in how they influence everyday food experiences
Rare serious risks include pancreatitis and gallbladder issues
You can fill the prescription at the pharmacy of your choice
Buying GLP-1s is not just a simple transaction, with no questions asked